*pItaly's pharmaceutical manufacturers' association, Farmindustria, says health spending is steady at 11,721 billion lire ($6.88 billion) this year, with a "small" 367 billion lire overshoot on the ceiling set for 1997. Of the total overshoot, 300 billion lire is the effect of the value added tax increases, while the remaining 67 billion lire is linked to the country's economic performance, according to Farmindustria.
In a statement to the press, Farmindustria denies that state pharmaceutical spending is "out of control." Data on regional spending point to only a 0.22% rise in drug sales at pharmacies, footed wholly or in part by the national health service, in the first three months of 1997, over a year earlier. This is lower than the 2.4% inflation rate for that period.
The Ministry of Health, meanwhile, has announced that it has not signed any provision to reclassify A drugs currently in the totally free category to patients. Rather, the Ministry intends to "solve within the week the problem, by adopting any possible solution in order to avoid a reclassification."
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2024 | Headless Content Management with Blaze